Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Falco Holdings CoTSE:4671 -0.22%72 PS Ratio is 0.62 as of Jul. 22, 2026, which is 48% above its 10-year median of 0.42. GuruFocus rates TSE:4671 with a GF Score™ of 72/100 and a GF Value™ of 円2,528.50 (Fairly Valued). The stock has 6 warning signs investors should review. Among 200 Medical Diagnostics & Research companies, Falco Holdings Co ranks better than 90% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Falco Holdings Co's share price is 円2695.00.
Falco Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円4,316.95. Hence, Falco Holdings Co's PS Ratio for today is 0.62.
Warning Sign:
Falco Holdings Co Ltd stock PS Ratio (=0.62) is close to 10-year high of 0.65.
The historical rank and industry rank for Falco Holdings Co's PS Ratio or its related term are showing as below:
TSE:4671'
s PS Ratio Range Over the Past 10 Years
Min: 0.3 Med: 0.42 Max: 0.65
Current: 0.63
During the past 13 years, Falco Holdings Co's highest PS Ratio was 0.65. The lowest was 0.30. And the median was 0.42.
TSE:4671's PS Ratio is ranked better than 90% of 200
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.685
vs TSE:4671: 0.63
Falco Holdings Co Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Falco Holdings Co was 6.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -0.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -1.20% per year.
During the past 13 years, Falco Holdings Co's highest 3-Year average Revenue per Share Growth Rate was 16.40% per year. The lowest was -5.30% per year. And the median was -0.90% per year.
Back to Basics: PS Ratio
Falco Holdings Co (TSE:4671) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Falco Holdings Co PS Ratio Related Terms
Falco Holdings Co PS Ratio Historical Data
* Premium members only.
The historical data trend for Falco Holdings Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Falco Holdings Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Falco Holdings Co PS Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Falco Holdings Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Falco Holdings Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Falco Holdings Co's Share Price of today is 円2695.00. Falco Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,316.95.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Falco Holdings Co (TSE:4671) has a PS Ratio of 0.62 as of Jul. 22, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Falco Holdings Co and its competitors. This is 48% above median its historical median of 0.42. Over the past decade, Falco Holdings Co's PS Ratio has ranged from 0.30 to 0.65. According to the industry distribution chart, Falco Holdings Co ranks #20 out of 200 companies in the Medical Diagnostics & Research industry, placing it in the top 10%.
Is Falco Holdings Co's PS Ratio too high?
Falco Holdings Co's current PS Ratio of 0.62 is 48% above median its 10-year median of 0.42. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 0.65. The Medical Diagnostics & Research industry median PS Ratio is 2.69. Falco Holdings Co's value of 0.62 is 76.9% below this industry median. Based on the distribution chart, Falco Holdings Co ranks #20 out of 200 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Falco Holdings Co has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Falco Holdings Co's PS Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Falco Holdings Co ranks #20 out of 200 companies for PS Ratio. This places Falco Holdings Co in the top 10% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.69. Falco Holdings Co's value of 0.62 is 76.9% below this benchmark. Historically, Falco Holdings Co's own PS Ratio has ranged from 0.30 to 0.65 over the past decade. While the company's 10-year median is 0.42 vs. the industry median of 2.69, Falco Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Diagnostics & Research company?
The median PS Ratio among Medical Diagnostics & Research companies is 2.69, based on 200 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Falco Holdings Co's current PS Ratio of 0.62 is 76.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Falco Holdings Co and its competitors. For the Medical Diagnostics & Research industry, the median PS Ratio is 2.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Falco Holdings Co's current PS Ratio is 0.62, which is 48% above median its own 10-year median of 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Falco Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Falco Holdings Co (TSE:4671) is currently considered Fairly Valued. The stock's GF Value™ is 円2,528.50, compared to a current price of 円2,695.00 — trading 6.6% above its estimated fair value. The current PS Ratio is 0.62, which is 48% above median its 10-year median of 0.42 and 76.9% below the Medical Diagnostics & Research industry median of 2.69. Falco Holdings Co's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Falco Holdings Co (TSE:4671), the current PS Ratio is 0.62 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Falco Holdings Co (TSE:4671) Overvalued in 2026?
Based on GuruFocus' analysis, Falco Holdings Co stock appears to be overvalued.
The current stock price of 円2,695.00 is trading 6.6% above its estimated GF Value™ of 円2,528.50.
GuruFocus considers Falco Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4671:
PS Ratio: 0.62 (48% above median its 10-year median of 0.42)
GF Value™: 円2,528.50 vs. price of 円2,695.00 (6.6% above fair value)
Industry Position: 76.9% below the Medical Diagnostics & Research median (#20 of 200)
No single metric tells the full story. See the TSE:4671 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Falco Holdings Co Ltd provides testing services. The company is engaged in providing clinical testing and genetic testing services, testing in clinical research and clinical trials, food sanitation, and environmental testing, and pharmacy business. It also engaged in providing information technology business.
72GF Score
Get the complete analysis for TSE:4671
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4671 has been successfully added to your 
